# 02_evidence_hybrid.yaml
# Evidências Híbridas - HemoDoctor + SADMH + Dev Team + Ajustes Dr. Abel Costa + Validação Externa
# Versão: v2.4.0
# Data: 2025-10-19
# Total: 79 evidências (64 base + 15 v2.3.2/v2.4.0)

version: evidence_hybrid_v2.4.0

# =============================================================================
# EVIDÊNCIAS CRÍTICAS (Short-Circuit Gates - Dev Team Base)
# =============================================================================
critical_evidences:
  # Neutropenia
  - id: E-ANC-VCRIT
    rule: "anc < 0.2"
    strength: strong
    description: "ANC < 0.2×10⁹/L (neutropenia muito grave)"
    clinical_significance: "Risco infeccioso extremo"
    source: "Dev Team + HemoDoctor SRS-001"
  
  - id: E-ANC-CRIT
    rule: "anc < 0.5"
    strength: strong
    description: "ANC < 0.5×10⁹/L (neutropenia grave)"
    clinical_significance: "Risco infeccioso alto"
    source: "Dev Team"
  
  # Leucocitose extrema
  - id: E-WBC-VERY-HIGH
    rule: "wbc > 100"
    strength: strong
    description: "WBC > 100×10⁹/L (leucocitose extrema)"
    clinical_significance: "Suspeita blástica/leucostase"
    source: "Dev Team"
  
  # Plaquetopenia crítica
  - id: E-PLT-CRIT-LOW
    rule: "plt < 10"
    strength: strong
    description: "PLT < 10×10⁹/L (plaquetopenia crítica)"
    clinical_significance: "Risco hemorrágico grave"
    source: "Dev Team + HemoDoctor SRS-001"
  
  # TMA morfológica
  - id: E-SCHISTOCYTES-GE1PCT
    rule: "morphology.esquistocitos == true"
    strength: strong
    description: "Esquistócitos presentes (≥1%)"
    clinical_significance: "TMA/MAT concern"
    source: "Dev Team"
  
  # Hemólise padrão
  - id: E-HEMOLYSIS-PATTERN
    rule: "(reticulocytes > 100) or (haptoglobin < 40) or (ldh > 500) or (bt_indireta > 1.0)"
    strength: strong
    description: "Padrão de hemólise (qualquer marcador positivo)"
    clinical_significance: "Hemólise ativa"
    source: "Dev Team"

# =============================================================================
# SÉRIE VERMELHA (15 evidências)
# =============================================================================
red_blood_cell_evidences:
  # Anemia
  - id: E-HB-CRIT-LOW
    rule: "hb < config.cutoffs.hb_critical_low[age_sex_group]"
    strength: strong
    description: "Hemoglobina crítica (ajustada por idade/sexo)"
    clinical_significance: "Anemia grave - risco de hipóxia"
    source: "HemoDoctor SRS-001 v3.0 + Ajustes Dr. Abel"
  
  # NOVO v2.3.1 — Hemoglobina/Hematócrito altos (PV/Eritrocitose)
  - id: E-HB-HIGH
    rule: "hb > config.cutoffs.hb_high[age_sex_group]"
    strength: strong
    description: "Hemoglobina alta por idade/sexo"
    clinical_significance: "Policitemia vera ou eritrocitose secundária"
    source: "Validação Externa v2.3.1 + WHO 2016 PV criteria"
  
  - id: E-HCT-HIGH
    rule: "ht > config.cutoffs.hct_high[age_sex_group]"
    strength: strong
    description: "Hematócrito alto por idade/sexo"
    clinical_significance: "Policitemia vera ou eritrocitose secundária"
    source: "Validação Externa v2.3.1"
  
  # Microcitose
  - id: E-MICROCYTOSIS
    rule: "mcv < config.cutoffs.mcv_low_adult"
    strength: moderate
    description: "Microcitose (MCV < 80 fL adulto ou < 75 fL criança)"
    clinical_significance: "IDA, talassemia, anemia inflamatória"
    source: "Dev Team + HemoDoctor"
  
  # Macrocitose
  - id: E-MACROCYTOSIS
    rule: "mcv > config.cutoffs.mcv_high_adult"
    strength: moderate
    description: "Macrocitose (MCV > 100 fL)"
    clinical_significance: "B12/folato, álcool, hipotireoidismo, MDS"
    source: "Dev Team + HemoDoctor"
  
  # Anisocitose
  - id: E-RDW-HIGH
    rule: "rdw > 14"
    strength: moderate
    description: "RDW elevado (> 14%)"
    clinical_significance: "Anisocitose - IDA, hemoglobinopatias"
    source: "Dev Team"
  
  # IDA labs
  - id: E-IDA-LABS
    rule: "(ferritin < 30) or (tsat < 20)"
    strength: moderate
    description: "Ferritina < 30 ng/mL ou TSat < 20%"
    clinical_significance: "Deficiência de ferro"
    source: "Dev Team + SADMH"
  
  # IDA + Inflamação
  - id: E-IDA-INFLAM
    rule: "(ferritin >= 30 and ferritin <= 100) and (tsat < 20) and (crp > 10)"
    strength: moderate
    description: "Ferritina 30-100 + TSat baixo + CRP elevado"
    clinical_significance: "Anemia ferropriva + inflamatória"
    source: "Ajustes Dr. Abel Costa"
  
  # Inflamação
  - id: E-INFLAM-HIGH
    rule: "crp > 10"
    strength: weak
    description: "CRP > 10 mg/L"
    clinical_significance: "Inflamação ativa"
    source: "Dev Team"
  
  # B12/Folato
  - id: E-B12-FOLATE-LOW
    rule: "(b12 < 300) or (folate < 3.1)"
    strength: moderate
    description: "B12 < 300 pg/mL ou Folato < 3.1 ng/mL"
    clinical_significance: "Deficiência vitamínica - anemia megaloblástica"
    source: "Dev Team"
  
  # Beta talassemia
  - id: E-BETA-THAL-TRAIT
    rule: "hba2 >= 3.5"
    strength: strong
    description: "HbA2 ≥ 3.5%"
    clinical_significance: "Traço beta-talassêmico"
    source: "SADMH + Ajustes Dr. Abel"
  
  # Alfa talassemia
  - id: E-ALFA-THAL-PATTERN
    rule: "(mcv < 80) and (rdw < 14) and (ferritin > 30)"
    strength: moderate
    description: "Microcitose + RDW normal + ferritina normal"
    clinical_significance: "Padrão sugestivo de alfa-talassemia"
    source: "Ajustes Dr. Abel Costa"
  
  # Morfologia - Drepanócitos
  - id: E-HB-SICKLE-MORPH
    rule: "morphology.drepanocitos == true"
    strength: strong
    description: "Drepanócitos presentes"
    clinical_significance: "Doença falciforme"
    source: "SADMH"
  
  # Morfologia - Esferócitos
  - id: E-ESFEROCITOS-PRESENT
    rule: "morphology.esferocitos == true"
    strength: moderate
    description: "Esferócitos presentes"
    clinical_significance: "Esferocitose hereditária ou hemólise autoimune"
    source: "HemoDoctor + SADMH"
  
  # Morfologia - Rouleaux
  - id: E-ROULEAUX-PRESENT
    rule: "morphology.rouleaux == true"
    strength: moderate
    description: "Rouleaux (hemácias empilhadas)"
    clinical_significance: "Mieloma múltiplo, inflamação"
    source: "SADMH + Ajustes Dr. Abel"
  
  # Morfologia - Dacrócitos
  - id: E-DACRIOCITOS-PRESENT
    rule: "morphology.dacriocitos == true"
    strength: moderate
    description: "Dacrócitos (tear drops)"
    clinical_significance: "Mielofibrose, talassemia"
    source: "SADMH"
  
  # Aplasia + Reticulócitos baixos
  - id: E-APLASIA-RETIC-LOW
    rule: "(hb < config.cutoffs.hb_critical_low[age_sex_group]) and (reticulocytes < 50)"
    strength: strong
    description: "Anemia grave + reticulócitos < 50×10⁹/L"
    clinical_significance: "Aplasia/crise aplástica (Parvovírus B19)"
    source: "Ajustes Dr. Abel Costa"

  # ============================================================================
  # BLOCO 3/3: Evidências 11-15 (Iron panel - IDA workup)
  # Adicionado: 2025-10-19 - Grupo A (Agente 3)
  # ============================================================================

  # 11. E-IRON-LOW
  - id: E-IRON-LOW
    rule: "iron < 50"
    strength: high
    description: "Serum iron <50 μg/dL"
    clinical_significance: "Iron deficiency anemia (IDA)"
    requires: ["iron"]
    source: "WHO 2011 IDA criteria"
    differential:
      - "Iron deficiency anemia (IDA)"
      - "Anemia of chronic disease (ACD) - sometimes"
    next_steps:
      - "Ferritin (if <30 → IDA confirmed)"
      - "TSAT (transferrin saturation)"
      - "TIBC (elevated in IDA)"
      - "Iron supplementation if IDA"

  # 12. E-TIBC-HIGH
  - id: E-TIBC-HIGH
    rule: "tibc > 450"
    strength: moderate
    description: "TIBC >450 μg/dL (increased iron-binding capacity)"
    clinical_significance: "Iron deficiency anemia (IDA)"
    requires: ["tibc"]
    source: "WHO 2011 IDA criteria"
    differential:
      - "Iron deficiency anemia (IDA)"
      - "Pregnancy"
    next_steps:
      - "Ferritin and TSAT"
      - "Iron supplementation if IDA confirmed"

  # 13. E-TSAT-LOW
  - id: E-TSAT-LOW
    rule: "transferrin_saturation < 20"
    strength: high
    description: "Transferrin saturation <20%"
    clinical_significance: "Iron deficiency anemia (IDA)"
    requires: ["transferrin_saturation"]
    source: "WHO 2011 IDA criteria"
    differential:
      - "Iron deficiency anemia (IDA)"
      - "Anemia of chronic disease (if ferritin high)"
    next_steps:
      - "Ferritin (differentiate IDA vs ACD)"
      - "If TSAT <20% + ferritin <30 → IDA confirmed"
      - "Iron therapy"

  # 14. E-SOLUBLE-TRANSFERRIN-RECEPTOR-HIGH
  - id: E-SOLUBLE-TRANSFERRIN-RECEPTOR-HIGH
    rule: "soluble_transferrin_receptor > 8.5"
    strength: moderate
    description: "Soluble transferrin receptor >8.5 mg/L"
    clinical_significance: "Iron deficiency, active erythropoiesis"
    requires: ["soluble_transferrin_receptor"]
    source: "WHO 2011 micronutrient guidelines"
    differential:
      - "Iron deficiency anemia (IDA)"
      - "Hemolysis (active erythropoiesis)"
      - "Thalassemia (ineffective erythropoiesis)"
    next_steps:
      - "sTfR/log ferritin ratio (>2 → IDA)"
      - "Hemoglobin electrophoresis if thalassemia suspected"

  # 15. E-HEPCIDIN-HIGH
  - id: E-HEPCIDIN-HIGH
    rule: "hepcidin > 100"
    strength: moderate
    description: "Hepcidin >100 ng/mL (iron absorption blockade)"
    clinical_significance: "Anemia of chronic disease (ACD)"
    requires: ["hepcidin"]
    source: "Nature Reviews Hematology 2023"
    differential:
      - "Anemia of chronic disease (ACD)"
      - "Inflammation"
      - "Infection"
      - "Malignancy"
    next_steps:
      - "Treat underlying inflammatory condition"
      - "IV iron if functional iron deficiency"
      - "EPO therapy if renal insufficiency"

# =============================================================================
# SÉRIE BRANCA (13 evidências - +1 em v2.3.1)
# =============================================================================
white_blood_cell_evidences:
  # Leucocitose
  - id: E-WBC-HIGH
    rule: "wbc > 11"
    strength: moderate
    description: "WBC > 11×10⁹/L"
    clinical_significance: "Leucocitose"
    source: "Ajustes Dr. Abel Costa"
  
  # NOVO v2.3.1 — Leucopenia (para pancitopenia)
  - id: E-WBC-LOW
    rule: "wbc < config.cutoffs.wbc_low[age_group]"
    strength: strong
    description: "Leucopenia por faixa etária"
    clinical_significance: "Pancitopenia, aplasia, MDS, quimioterapia"
    source: "Validação Externa v2.3.1"
  
  # Left shift morfológico
  - id: E-LEFT-SHIFT
    rule: "morphology.bastoes == true or morphology.mielocitos == true or morphology.metamielocitos == true"
    strength: moderate
    description: "Desvio à esquerda (bastões/mielócitos/metamielócitos)"
    clinical_significance: "Infecção, LMC, reação leucemoide"
    source: "Ajustes Dr. Abel Costa"
  
  # ANC elevado
  - id: E-ANC-HIGH
    rule: "anc > 10"
    strength: moderate
    description: "ANC > 10×10⁹/L"
    clinical_significance: "Neutrofilia grave"
    source: "Ajustes Dr. Abel Costa"
  
  # Blastos
  - id: E-BLASTS-PRESENT
    rule: "morphology.blastos == true"
    strength: strong
    description: "Blastos presentes"
    clinical_significance: "Leucemia aguda, SMD high-grade"
    source: "Dev Team + HemoDoctor"
  
  # Promielócitos
  - id: E-PROMIELOCITOS-PRESENT
    rule: "morphology.promielocitos == true"
    strength: strong
    description: "Promielócitos presentes"
    clinical_significance: "LPA (M3), reação leucemoide"
    source: "Ajustes Dr. Abel Costa"
  
  # Linfocitose
  - id: E-LYMPHOCYTOSIS
    rule: "lymphocytes_abs > 5"
    strength: moderate
    description: "Linfócitos > 5×10⁹/L"
    clinical_significance: "LLC, linfoma, viral"
    source: "Dev Team + SADMH"
  
  # Linfócitos atípicos
  - id: E-LYMPH-ATYPICAL
    rule: "morphology.linfocitos_atipicos == true"
    strength: moderate
    description: "Linfócitos atípicos presentes"
    clinical_significance: "Infecção viral (EBV, CMV)"
    source: "HemoDoctor + SADMH"
  
  # Eosinofilia
  - id: E-EOS-HIGH
    rule: "eosinophils_abs >= 1.5"
    strength: moderate
    description: "Eosinófilos ≥ 1.5×10⁹/L"
    clinical_significance: "Parasitas, alergia, NMP"
    source: "Dev Team + Ajustes Dr. Abel"
  
  # Basofilia
  - id: E-BASO-HIGH
    rule: "basophils_abs >= 0.2"
    strength: weak
    description: "Basófilos ≥ 0.2×10⁹/L"
    clinical_significance: "NMP (LMC), alergia"
    source: "Dev Team + Ajustes Dr. Abel"
  
  # Monocitose
  - id: E-MONOCYTOSIS
    rule: "monocytes_abs > 1.0"
    strength: moderate
    description: "Monócitos > 1.0×10⁹/L"
    clinical_significance: "LMMC, infecção crônica"
    source: "Ajustes Dr. Abel Costa"
  
  # Leucoeritroblastose
  - id: E-LEUCOERITROBLASTOSE
    rule: "(morphology.mielocitos == true or morphology.metamielocitos == true) and (morphology.policromasia == true)"
    strength: moderate
    description: "Leucoeritroblastose (imaturos + policromasia)"
    clinical_significance: "Mielofibrose, infiltração medular, sepse"
    source: "Ajustes Dr. Abel Costa"
  
  # CRP elevado
  - id: E-CRP-HIGH
    rule: "crp > 10"
    strength: weak
    description: "CRP > 10 mg/L"
    clinical_significance: "Inflamação/infecção"
    source: "Ajustes Dr. Abel Costa"

# =============================================================================
# SÉRIE PLAQUETÁRIA (8 evidências)
# =============================================================================
platelet_evidences:
  # Trombocitose moderada
  - id: E-PLT-HIGH
    rule: "plt > 450"
    strength: moderate
    description: "PLT > 450×10⁹/L"
    clinical_significance: "Trombocitose (reativa vs clonal)"
    source: "Dev Team"
  
  # Trombocitose muito alta
  - id: E-PLT-VERY-HIGH
    rule: "plt >= 650"
    strength: strong
    description: "PLT ≥ 650×10⁹/L"
    clinical_significance: "Trombocitose clonal provável (NMP)"
    source: "Dev Team + Ajustes Dr. Abel"
  
  # Pseudo-trombocitopenia morfológica
  - id: E-PSEUDO-THROMBO
    rule: "morphology.aglomerados_plaquetarios == true or mpv > 12"
    strength: strong
    description: "Aglomerados plaquetários ou MPV > 12 fL"
    clinical_significance: "Pseudo-trombocitopenia (EDTA)"
    source: "Dev Team"
  
  # Trombocitose persistente (metadata)
  - id: E-THROMBOCYTOSIS-PERSIST
    rule: "metadata.persistent_thrombocytosis == true"
    strength: moderate
    description: "Trombocitose persistente (>2 CBCs em 2-6 sem)"
    clinical_significance: "Aumenta suspeita clonal"
    source: "Ajustes Dr. Abel Costa"
    optional: true
  
  # Perfil clonal (exclusão reativo)
  - id: E-CLONAL-PROFILE
    rule: "(crp <= 10 or crp unknown) and (ferritin <= 30 or ferritin unknown) and (tsat <= 20 or tsat unknown)"
    strength: moderate
    description: "Perfil não reativo (CRP/ferritina/TSat normais ou ausentes)"
    clinical_significance: "Exclusão de causas reativas"
    source: "Ajustes Dr. Abel Costa"
  
  # Plaquetas gigantes
  - id: E-PLT-GIGANTES
    rule: "morphology.plaquetas_gigantes == true"
    strength: moderate
    description: "Plaquetas gigantes presentes"
    clinical_significance: "NMP, Bernard-Soulier"
    source: "SADMH"
  
  # Trombocitopenia
  - id: E-PLT-LOW
    rule: "plt < 150"
    strength: moderate
    description: "PLT < 150×10⁹/L"
    clinical_significance: "Trombocitopenia"
    source: "HemoDoctor SRS-001"
  
  # MPV elevado
  - id: E-MPV-HIGH
    rule: "mpv > 12"
    strength: weak
    description: "MPV > 12 fL"
    clinical_significance: "Plaquetas jovens ou pseudo-trombocitopenia"
    source: "Dev Team"

# =============================================================================
# COAGULAÇÃO (5 evidências - V1.2)
# =============================================================================
coagulation_evidences:
  # D-dímero elevado
  - id: E-D-DIMER-HIGH
    rule: "d_dimer > 500"
    strength: moderate
    description: "D-dímero > 500 ng/mL"
    clinical_significance: "CIVD, TEV"
    source: "Ajustes Dr. Abel Costa"
    v1_2: true
  
  # Fibrinogênio baixo
  - id: E-FIBRINOGEN-LOW
    rule: "fibrinogenio < 150"
    strength: strong
    description: "Fibrinogênio < 150 mg/dL"
    clinical_significance: "CIVD, hipofibrinogenemia"
    source: "Ajustes Dr. Abel Costa"
    v1_2: true
  
  # PT/APTT prolongado
  - id: E-PT-APTT-PROLONGED
    rule: "(pt > normal_high) or (aptt > normal_high)"
    strength: moderate
    description: "PT ou APTT prolongado"
    clinical_significance: "CIVD, deficiência fatores, anticoagulação"
    source: "Ajustes Dr. Abel Costa"
    v1_2: true
  
  # Painel coagulação anormal
  - id: E-COAG-PANEL-ABNORMAL
    rule: "E-D-DIMER-HIGH and (E-FIBRINOGEN-LOW or E-PT-APTT-PROLONGED)"
    strength: strong
    description: "Painel de coagulação anormal (≥2 marcadores)"
    clinical_significance: "CIVD provável"
    source: "Ajustes Dr. Abel Costa"
    v1_2: true
  
  # Score ISTH CIVD
  - id: E-DIC-SCORE-HIGH
    rule: "dic_isth_score >= 5"
    strength: strong
    description: "Score ISTH CIVD ≥ 5"
    clinical_significance: "CIVD confirmada"
    source: "Ajustes Dr. Abel Costa"
    v1_2: true
    optional: true

# =============================================================================
# MOLECULARES (10 evidências)
# =============================================================================
molecular_evidences:
  # NMP drivers
  - id: E-JAK2-CALR-MPL-POS
    rule: "jak2_pos == true or calr_pos == true or mpl_pos == true"
    strength: strong
    description: "JAK2/CALR/MPL positivo"
    clinical_significance: "NMP (PV, TE, MFP)"
    source: "Dev Team + SADMH"
  
  # LMC
  - id: E-BCR-ABL-POS
    rule: "bcr_abl_pos == true"
    strength: strong
    description: "BCR-ABL positivo"
    clinical_significance: "LMC"
    source: "Dev Team"
  
  # Hemólise autoimune
  - id: E-COOMBS-POS
    rule: "coombs_pos == true"
    strength: moderate
    description: "Coombs Direto positivo"
    clinical_significance: "Hemólise autoimune"
    source: "Dev Team + SADMH"
  
  # G6PD
  - id: E-G6PD-DEFICIENT
    rule: "g6pd_deficient == true"
    strength: moderate
    description: "G6PD deficiente"
    clinical_significance: "Hemólise oxidativa"
    source: "Dev Team + SADMH"
  
  # PK
  - id: E-PK-DEFICIENT
    rule: "pk_deficient == true"
    strength: moderate
    description: "Piruvato Quinase deficiente"
    clinical_significance: "Anemia hemolítica congênita"
    source: "Dev Team"
  
  # PNH
  - id: E-HPN-POS
    rule: "hpn_pos == true"
    strength: strong
    description: "HPN (PNH) - CD55/CD59 deficientes"
    clinical_significance: "Hemoglobinúria Paroxística Noturna"
    source: "Dev Team + SADMH"
  
  # Mieloma
  - id: E-FLC-RATIO-ABNORMAL
    rule: "flc_ratio_abnormal == true"
    strength: moderate
    description: "Free Light Chains ratio anormal"
    clinical_significance: "Mieloma múltiplo, MGUS"
    source: "Dev Team + Ajustes Dr. Abel"
  
  # LPA (M3) - V1.3
  - id: E-PMLRARA-POS
    rule: "pmlrara_pos == true"
    strength: strong
    description: "PML-RARA positivo"
    clinical_significance: "Leucemia Promielocítica Aguda (LPA/M3)"
    source: "Ajustes Dr. Abel Costa"
    v1_3: true
  
  # EPO elevado - V1.3
  - id: E-EPO-HIGH
    rule: "epo > normal_high"
    strength: moderate
    description: "Eritropoetina elevada"
    clinical_significance: "Eritrocitose secundária (hipóxia, rim)"
    source: "Ajustes Dr. Abel Costa"
    v1_3: true
  
  # EPO baixo - V1.3
  - id: E-EPO-LOW
    rule: "epo < normal_low"
    strength: moderate
    description: "Eritropoetina baixa"
    clinical_significance: "Policitemia Vera"
    source: "Ajustes Dr. Abel Costa"
    v1_3: true

# =============================================================================
# LABORATÓRIO SUPLEMENTAR (5 evidências - v2.3.2)
# Adicionado: 2025-10-19 - Grupo A (Agente 2)
# =============================================================================
supplementary_lab_evidences:
  # 6. E-TSH-ABNORMAL
  - id: E-TSH-ABNORMAL
    rule: "tsh < 0.5 or tsh > 5.0"
    strength: low
    description: "TSH anormal (hypothyroidism or hyperthyroidism)"
    clinical_significance: "Secondary anemia due to thyroid dysfunction"
    requires: ["tsh"]
    source: "Endocrine Society 2023 guidelines"
    differential:
      - "Hypothyroidism (TSH >5.0)"
      - "Hyperthyroidism (TSH <0.5)"
      - "Subclinical thyroid disease"
    next_steps:
      - "Free T4"
      - "Thyroid antibodies if autoimmune suspected"
      - "Treat thyroid disorder (may improve anemia)"

  # 7. E-VIT-B12-LOW
  - id: E-VIT-B12-LOW
    rule: "vitamin_b12 < 200"
    strength: moderate
    description: "Vitamin B12 <200 pg/mL"
    clinical_significance: "Megaloblastic anemia, neuropathy"
    requires: ["vitamin_b12"]
    source: "WHO 2016 micronutrient guidelines"
    differential:
      - "Pernicious anemia (autoimmune)"
      - "Malabsorption (Crohn's, celiac)"
      - "Dietary deficiency (vegan)"
      - "Medications (metformin, PPI)"
    next_steps:
      - "MMA and homocysteine (confirm deficiency)"
      - "Intrinsic factor antibodies"
      - "B12 replacement therapy"

  # 8. E-FOLATO-LOW
  - id: E-FOLATO-LOW
    rule: "folate < 3.0"
    strength: moderate
    description: "Folate <3.0 ng/mL"
    clinical_significance: "Megaloblastic anemia"
    requires: ["folate"]
    source: "WHO 2016 micronutrient guidelines"
    differential:
      - "Dietary deficiency"
      - "Malabsorption (celiac, Crohn's)"
      - "Increased demand (pregnancy, hemolysis)"
      - "Medications (methotrexate, trimethoprim)"
    next_steps:
      - "Folate supplementation"
      - "Screen for celiac disease if malabsorption"
      - "B12 level (exclude combined deficiency)"

  # 9. E-RETICULOCYTES-LOW
  - id: E-RETICULOCYTES-LOW
    rule: "reticulocytes < 0.5"
    strength: high
    description: "Reticulocytes <0.5% (inadequate marrow response)"
    clinical_significance: "Aplastic anemia, marrow failure, nutritional deficiency"
    requires: ["reticulocytes"]
    source: "NCCN 2023 hematology guidelines"
    differential:
      - "Aplastic anemia"
      - "Pure red cell aplasia (PRCA)"
      - "MDS (myelodysplastic syndrome)"
      - "Nutritional deficiency (B12, folate, iron)"
    next_steps:
      - "Bone marrow biopsy if pancytopenia"
      - "Iron, B12, folate studies"
      - "Hematology consult"

  # 10. E-RETICULOCYTES-HIGH
  - id: E-RETICULOCYTES-HIGH
    rule: "reticulocytes > 2.0"
    strength: moderate
    description: "Reticulocytes >2.0% (appropriate marrow response)"
    clinical_significance: "Hemolysis, bleeding, or EPO therapy"
    requires: ["reticulocytes"]
    source: "NCCN 2023 hematology guidelines"
    differential:
      - "Hemolytic anemia"
      - "Acute bleeding"
      - "Recovery from marrow suppression"
      - "EPO therapy response"
    next_steps:
      - "LDH and indirect bilirubin (if hemolysis)"
      - "Blood smear"
      - "Haptoglobin (low in hemolysis)"

# =============================================================================
# PRÉ-ANALÍTICO (5 evidências)
# =============================================================================
pre_analytical_evidences:
  # MCHC implausível
  - id: E-PRE-MCHC-IMPLAUS
    rule: "mchc > 37 or mchc < 25"
    strength: strong
    description: "MCHC > 37 ou < 25 g/dL (impossível fisiologicamente)"
    clinical_significance: "Erro pré-analítico (aglutinação, lipemia)"
    source: "Ajustes Dr. Abel Costa"
  
  # Suspeita aglomerados (sem morfologia)
  - id: E-PRE-CLUMPS-SUSPECT
    rule: "(plt < 100) and (mpv > 12)"
    strength: moderate
    description: "PLT < 100 + MPV > 12 (sem morfologia confirmatória)"
    clinical_significance: "Suspeita pseudo-trombocitopenia"
    source: "Ajustes Dr. Abel Costa"
  
  # Inconsistência Hb/Ht/MCHC
  - id: E-PRE-HB-HT-INCONSIST
    rule: "abs((hb/ht)*100 - mchc) > 2"
    strength: moderate
    description: "Inconsistência entre Hb, Ht e MCHC (>2 g/dL)"
    clinical_significance: "Erro pré-analítico"
    source: "Ajustes Dr. Abel Costa"
  
  # Aglutinina fria
  - id: E-PRE-COLD-AGGLUTININ
    rule: "(mchc > 37) and (mcv < 80) and (hb < config.cutoffs.hb_critical_low[age_sex_group])"
    strength: moderate
    description: "MCHC > 37 + microcitose + anemia"
    clinical_significance: "Suspeita aglutinina fria"
    source: "Ajustes Dr. Abel Costa"
  
  # Lipemia (metadata)
  - id: E-PRE-LIPEMIA-SUSPECT
    rule: "metadata.sample_lipemic == true"
    strength: weak
    description: "Amostra lipêmica (metadata flag)"
    clinical_significance: "Interferência Hb por lipemia"
    source: "Ajustes Dr. Abel Costa"
    optional: true

# =============================================================================
# BLOCO 1/3: Evidências Complementares (Anemia, Ferritina, LDH, Bilirrubina, Creatinina)
# Adicionadas: 2025-10-19 - Implementação BUG-006
# =============================================================================
complementary_evidences:
  # 1. E-ANEMIA - CRÍTICO! S-PANCYTOPENIA depende
  - id: E-ANEMIA
    rule: "hb < config.cutoffs.hb_low[age_sex_group]"
    strength: moderate
    description: "Anemia por idade/sexo"
    clinical_significance: "Múltiplas causas (IDA, ACD, hemólise, aplasia, etc.)"
    requires: ["hb", "age_months", "sex"]
    source: "WHO 2011 anemia criteria"
    differential:
      - "IDA (iron deficiency anemia)"
      - "ACD (anemia of chronic disease)"
      - "Hemolysis"
      - "Aplastic anemia"
      - "MDS"
    next_steps:
      - "Reticulocyte count"
      - "Iron panel (ferritin, TSAT, TIBC)"
      - "B12 and folate"
  
  # 2. E-FERRITIN-HIGH-100 - S-ACD usa!
  - id: E-FERRITIN-HIGH-100
    rule: "ferritin > 100"
    strength: moderate
    description: "Ferritina >100 ng/mL"
    clinical_significance: "ACD, iron overload, inflammation, malignancy"
    requires: ["ferritin"]
    source: "NCCN 2023 anemia guidelines"
    differential:
      - "Anemia of chronic disease (ACD)"
      - "Hemochromatosis"
      - "Acute phase reactant (infection, inflammation)"
      - "Malignancy"
    next_steps:
      - "CRP (confirm inflammation)"
      - "TSAT (differentiate ACD vs overload)"
      - "Treat underlying condition"
  
  # 3. E-LDH-HIGH - S-TMA e S-HEMOLYSIS usam!
  - id: E-LDH-HIGH
    rule: "ldh > config.cutoffs.ldh_high"
    strength: high
    description: "LDH elevado"
    clinical_significance: "Hemolysis, TMA, tissue damage, malignancy"
    requires: ["ldh"]
    source: "ISTH 2023 hemolysis criteria"
    differential:
      - "Hemolysis (intravascular or extravascular)"
      - "TMA (thrombotic microangiopathy)"
      - "Myocardial infarction"
      - "Malignancy"
      - "Liver disease"
    next_steps:
      - "Indirect bilirubin (confirm hemolysis)"
      - "Haptoglobin (low in hemolysis)"
      - "Blood smear (schistocytes if TMA)"
      - "Reticulocyte count (elevated in hemolysis)"
  
  # 4. E-BT-IND-HIGH - S-HEMOLYSIS usa!
  - id: E-BT-IND-HIGH
    rule: "bilirubin_indirect > 1.2"
    strength: high
    description: "Bilirrubina indireta >1.2 mg/dL"
    clinical_significance: "Hemolysis, Gilbert syndrome"
    requires: ["bilirubin_indirect"]
    source: "Clinical chemistry reference ranges"
    differential:
      - "Hemolysis (hemolytic anemia, TMA)"
      - "Gilbert syndrome"
      - "Ineffective erythropoiesis (MDS, thalassemia)"
    next_steps:
      - "LDH (if elevated → hemolysis)"
      - "Haptoglobin (low → hemolysis)"
      - "Reticulocyte count"
      - "Blood smear"
  
  # 5. E-CREATININA-HIGH - S-TMA usa!
  - id: E-CREATININA-HIGH
    rule: "creatinine > config.cutoffs.creatinine_high[age_sex_group]"
    strength: moderate
    description: "Creatinina elevada (kidney injury)"
    clinical_significance: "TMA (renal involvement), AKI, CKD"
    requires: ["creatinine", "age_months", "sex"]
    source: "KDIGO 2023 AKI criteria"
    differential:
      - "TMA (HUS, aHUS, TTP)"
      - "Acute kidney injury (AKI)"
      - "Chronic kidney disease (CKD)"
      - "Rhabdomyolysis"
    next_steps:
      - "Urinalysis (proteinuria, hematuria)"
      - "BUN (assess kidney function)"
      - "If TMA suspected: ADAMTS13, complement studies"
      - "Nephrology consult if persistent"

# =============================================================================
# METADADOS E NOTAS
# =============================================================================
metadata:
  total_evidences: 79
  critical_count: 6
  strong_count: 25
  high_count: 5
  moderate_count: 48
  weak_count: 5
  low_count: 1

  sources:
    dev_team: 28
    hemodoctor: 18
    sadmh: 12
    ajustes_dr_abel: 17
    who_guidelines: 3
    endocrine_society: 1
    nccn: 2

  version_distribution:
    v1_0: 64
    v1_2_coagulation: 5
    v1_3_molecular: 3
    v2_3_2_supplementary: 2

notes: |
  - Evidências críticas (E-ANC-VCRIT, E-WBC-VERY-HIGH, E-PLT-CRIT-LOW, E-SCHISTOCYTES-GE1PCT) 
    acionam short-circuit nas síndromes críticas
  - Evidências com "optional: true" requerem metadata adicional (persistência, lipemia)
  - Evidências v1.2 (coagulação) e v1.3 (EPO, PML-RARA) serão habilitadas em releases futuros
  - Todas as regras usam cutoffs de 00_config_hybrid.yaml para ajuste idade/sexo
  - Morfologia triestado: true/false/unknown (unknown é tratado por 05_missingness_hybrid.yaml)

# =============================================================================
# FIM DO ARQUIVO
# =============================================================================

